ArticleCancers2022

EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer.

Carolin Selenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.